Psychopharm Today

Psychopharm Today

Health EN ↓ 6 episodes

“Psychopharm Today” is the collaborative podcast between Psychiatric Times and the American Society of Clinical Psychopharmacology (ASCP).  This podcast examines the hottest topics in clinical psychopharmacology and their impact on the field of psychiatry.

Be sure to visit the podcast's website and support the creator: www.psychiatrictimes.com

Author

Psychopharm Today

Category

Health

Podcast website

www.psychiatrictimes.com

Latest episode

Nov 19, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

6: NIH Team Details Path From Ketamine Metabolite Discovery to Phase 2 Trials 19.11.2026

In this episode of “Psychopharm Today,” host Jenessa Johnston, PhD, and guests Carlos Zarate, MD; Todd Gould, MD; and Craig J. Thomas, PhD, described the development of 2R,6R-hydroxynorketamine (2R,6R-HNK) for depression and pain. The program began with a mismatch. Across replicated clinical studies, a single ketamine infusion produced antidepressant effects within hours that persisted 1 to 2 week...

5: A Learning Health Network to Improve Bipolar Outcomes With Andrew Nierenberg, MD 08.10.2026

In this episode of “Psychopharm Today,” host Jessica Gannon, MD speaks with Andrew A. Nierenberg, MD, the Thomas P. Hackett, MD, Endowed Chair in Psychiatry at Massachusetts General Hospital (MGH) and director of the Dauten Family Center for Bipolar Treatment Innovation. Most clinicians cannot say how their patients are doing overall. The Bipolar Action Network aims to change that, shared Nierenbe...

4: Treatment Resistance, Placebo Response, and What Comes Next With Maurizio Fava, MD 10.09.2026

In this episode of “Psychopharm Today,” guest Maurizio Fava, MD, sat down for a wide-ranging conversation with host Michael E. Henry, MD, about the career instincts and collaborations that have shaped his decades-long work on treatment-resistant depression, placebo response, and ketamine. Fava traced his focus on treatment-resistant depression back to his early years at Massachusetts General Hospi...

3: Exploring Entactogens With Hiroe Imai Hu, DO, and James W. Murrough, MD, PhD 13.08.2026

In this episode of “Psychopharm Today,” host Jenessa Johnston, PhD, and guests James Murrough, MD, PhD, of the Icahn School of Medicine at Mount Sinai, and Hiroe Hu, DO, a clinical research fellow in the National Institute of Mental Health's (NIMH) Experimental Therapeutics and Pathophysiology Branch, discuss the case for entactogens in mood and anxiety disorders. The conversation explores entacto...

2: A Transdiagnostic Approach to Metabolic Health and Mental Illness 09.07.2026

Metabolic syndrome screening is important for all patients with psychiatric disorders, not just those on antipsychotics. Careful communication of metabolic risk is needed to avoid unintended consequences, such as medication nonadherence. In the second episode of “Psychopharm Today,” host Jessica Gannon, MD, and guests Benjamin I. Perry, PhD; Nicolette Stogios, PhD; and Katharine Liang, MD, PhD, di...

1: Limitations of Current Diagnosis-Based Frameworks in Suicide Research: A Conversation With Jill Harkavy-Friedman, PhD, and Elizabeth Ballard, PhD 11.06.2026

“Psychopharm Today” is a video-podcast series, created collaboratively with the American Society of Clinical Psychopharmacology (ASCP) , in which members converse about the latest hot topics in psychopharmacology. Suicide is the eleventh leading cause of death overall in the United States, claiming the lives of over 49,300 people. In this inaugural episode of “Psychopharm Today,” host Jenessa John...

Listen to the Psychopharm Today podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.